XML 27 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jan. 03, 2025
Dec. 29, 2023
Dec. 30, 2022
Statement of Cash Flows [Abstract]      
Net income $ 521,267 $ 207,765 $ 182,282
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 28,803 25,717 20,875
Impairment of long-lived assets 64,391 0 0
Stock-based compensation 93,836 106,345 107,574
Non-cash lease expense 27,461 28,976 18,315
Deferred taxes (59,458) (133,209) (60,358)
Acquired in-process research and development technology 50,750 128,500 107,250
Other, net (13,626) (16,797) (525)
Changes in operating assets and liabilities:      
Trade receivable, net (27,950) (22,623) 66,849
Inventory 5,453 (12,977) (11,683)
Prepaid expenses and other assets 31,079 (29,824) (28,259)
Accrued collaboration liabilities (149) 1,345 (63,065)
Accounts payable and other liabilities (21,886) 50,106 23,359
Net cash provided by operating activities 699,971 333,324 362,614
Cash flows from investing activities:      
Purchases of marketable securities (927,905) (902,468) (1,450,716)
Proceeds from maturities and sales of marketable securities 877,307 1,038,482 1,064,758
Purchases of property, equipment and other, net (28,435) (40,469) (27,706)
Acquired in-process research and development technology (37,750) (122,500) (110,750)
Net cash used in investing activities (116,783) (26,955) (524,414)
Cash flows from financing activities:      
Payments for repurchases of common stock (652,033) (550,378) 0
Proceeds from issuance of common stock under the equity incentive plan and stock purchase plan 61,850 33,448 23,886
Taxes paid related to net share settlement of equity awards (38,625) (29,122) (23,300)
Net cash provided by (used in) financing activities (628,808) (546,052) 586
Net decrease in cash and cash equivalents (45,620) (239,683) (161,214)
Cash and cash equivalents at beginning of period 262,994 502,677 663,891
Cash and cash equivalents at end of period 217,374 262,994 502,677
Supplemental cash flow disclosures:      
Cash paid for taxes 170,482 185,658 127,870
Non-cash operating activities:      
Right-of-use assets obtained in exchange for lease obligations 15,313 16,623 155,935
Impairment of right-of-use assets 59,735 0 0
Non-cash investing activity:      
Unpaid liabilities incurred for purchases of in-process research and development technology $ 19,500 $ 6,500 $ 500